If you respect the word of this neurologist, Mark Malkin, out of the Cleveland Clinic, then perhaps you might consider respecting the word of these 66 non affiliated neurosurgeons and neuro-oncologists that I've listed below from these other highly respected medical centers who found the overall survival results of the DCVax-L P3 trial to be clinically meaningful and statistically significant in newly diagnosed and recurrent GBM.
Linda M. Liau, MD, PhD1; Keyoumars Ashkan, MD, FRCP, FRCS2; Steven Brem, MD3; Jian L. Campian, MD, PhD4; John E. Trusheim, MD5; Fabio M. Iwamoto, MD6,7; David D. Tran, MD, PhD8; George Ansstas, MD9; Charles S. Cobbs, MD10; Jason A. Heth, MD11; Michael E. Salacz, MD12; Stacy D’Andre, MD13; Robert D. Aiken, MD14; Yaron A. Moshel, MD, PhD14; Joo Y. Nam, MD15; Clement P. Pillainayagam, MD16; Stephanie A. Wagner, MD17; Kevin A. Walter, MD18; Rekha Chaudhary, MD19; Samuel A. Goldlust, MD20; Ian Y. Lee, MD21; Daniela A. Bota, MD, PhD22; Heinrich Elinzano, MD23; Jai Grewal, MD24; Kevin Lillehei, MD25; Tom Mikkelsen, MD, FRCPC21; Tobias Walbert, MD21; Steven Abram, MD26; Andrew J. Brenner, MD, PhD27; Matthew G. Ewend, MD28; Simon Khagi, MD29; Darren S. Lovick, MD30; Jana Portnow, MD31; Lyndon Kim, MD32; William G. Loudon, MD33; Nina L. Martinez, MD34; Reid C. Thompson, MD35; David E. Avigan, MD36; Karen L. Fink, MD, PhD37; Francois J. Geoffroy, MD38; Pierre Giglio, MD39; Oleg Gligich, MD40; Dietmar Krex, MD41; Scott M. Lindhorst, MD42; Jose Lutzky, MD43; Hans-Jörg Meisel, MD, PhD44; Minou Nadji-Ohl, MD45; Lhagva Sanchin, MD44; Andrew Sloan, MD46; Lynne P. Taylor, MD47; Julian K. Wu, MD47; Erin M. Dunbar, MD48; Arnold B. Etame, MD, PhD49; Santosh Kesari, MD, PhD50; David Mathieu, MD51; David E. Piccioni, MD, PhD52; David S. Baskin, MD53; Michel Lacroix, MD54; Sven-Axel May, MD55; Pamela Z. New, MD56; Timothy J. Pluard, MD57; Steven A. Toms, MD58; Victor Tse, MD59; Scott Peak, MD59; John L. Villano, MD, PhD60; James D. Battiste, MD, PhD61; Paul J. Mulholland, MD62; Michael L. Pearlman, MD63; Kevin Petrecca, MD, PhD64; Michael Schulder, MD65; Robert M. Prins, PhD66
1Department of Neurosurgery, University of California, Los Angeles
2King’s College Hospital, London, United Kingdom
3Department of Neurosurgery, Penn Brain Tumor Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia
4Division of Neurology, Washington University School of Medicine in St Louis, St Louis, Missouri
5Givens Brain Tumor Center, Abbott Northwestern Hospital, Minneapolis, Minnesota
6Columbia University Irving Medical Center, New York, New York
7New York-Presbyterian Hospital, New York, New York
8Preston A. Wells, Jr. Center for Brain Tumor Therapy, Division of Neuro-Oncology, Lillian S. Wells Department of Neurosurgery, University of Florida College of Medicine, Gainesville
9Department of Neurological Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri
10Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Medical Center, Seattle, Washington
11Taubman Medical Center, University of Michigan, Ann Arbor
12Neuro-Oncology Program, Rutgers Cancer Institute of New Jersey, New Brunswick
13Sutter Health, Sacramento, California
14Glasser Brain Tumor Center, Atlantic Healthcare, Summit, New Jersey
15Department of Neurological Sciences, Rush Medical College, Chicago, Illinois
16Department of Neurology, The Ohio State University, Columbus
17The Cancer Center of Columbus Regional Health, Columbus, Indiana
18University of Rochester, Rochester, New York
19University of Cincinnati, Cincinnati, Ohio
20John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey
21Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan
22Department of Neurology and Chao Family Comprehensive Cancer Center, University of California, Irvine
23Rhode Island Hospital, Providence
24Long Island Brain Tumor Center at NSPC, Lake Success, New York
25Department of Neurosurgery, University of Colorado Health Sciences Center, Boulder
26Ascension St Thomas Brain and Spine Tumor Center, Howell Allen Clinic, Nashville, Tennessee
27Mays Cancer Center at UT Health San Antonio, San Antonio, Texas
28Department of Neurosurgery, UNC School of Medicine and UNC Health, Chapel Hill, North Carolina
29The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
30Advent Health, Kansas City, Kansas
31Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California
32Division of Neuro-Oncology, Icahn School of Medicine at Mount Sinai, New York, New York
33Saint Joseph’s Hospital, Orange, California
34Jefferson Hospital for Neurosciences, Jefferson University, Philadelphia, Pennsylvania
35Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
36Beth Israel Deaconess Medical Center, Harvard Medical School, Cambridge, Massachusetts
37Baylor Scott & White Neuro-Oncology Associates, Dallas, Texas
38Illinois Cancer Care, Galesburg, Peoria
39Medical University of South Carolina Neurosciences, Charleston
40Mount Sinai Medical Center, Miami Beach, Florida
41Uniklinikum Dresden, Dresden, Germany
42Hollings Cancer Center, Medical University of South Carolina, Charleston
43Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida
44BG Klinikum Bergmannstrost, Halle, Germany
45Neurochirurgie Katharinenhospital, Klinikum der Landeshauptstadt Stuttgart, Stuttgart, Germany
46Seidman Cancer Center, University Hospitals–Cleveland Medical Center, Cleveland, Ohio
47Department of Neurosurgery, Tufts Medical Center, Boston, Massachusetts
48Piedmont Physicians Neuro-Oncology, Piedmont Brain Tumor Center, Atlanta, Georgia
49Department of Neuro-Oncology, Moffitt Cancer Center
50Pacific Neurosciences Institute and Saint John’s Cancer Institute, Santa Monica, California
51Centre de Recherche du CHUS, Université de Sherbrooke, Sherbrooke, Quebec, Canada
52UC San Diego Moore’s Cancer Center, La Jolla, California
53Department of Neurosurgery, Houston Methodist Hospital, Houston, Texas
54Geisinger Neuroscience Institute, Danville, Pennsylvania
55Klinik für Neurochirurgie, Chemnitz, Germany
56Baptist Health System, San Antonio, Texas
57Saint Luke’s Cancer Institute, Kansas City, Missouri
58Departments of Neurosurgery and Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
59Kaiser Permanente, Redwood City, California
60University of Kentucky Markey Cancer Center, Department of Medicine, Neurosurgery, and Neurology, University of Kentucky, Lexington
61Oklahoma University Health Science Center, Oklahoma City
62University College London Hospitals, London, United Kingdom
63Blue Sky Neurology/Neuro-Oncology, Englewood, California
64Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada
65Department of Neurosurgery, Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York
66University of California, Los Angeles
Note: Dr. Mark Malkin obviously had enough respect for Al Musella and his knowledge on the subject of brain cancer that he chose to spend his time doing an rather lengthy interview with him, as have many other neuro-surgeons and neuro-oncologists.
Market Data 
Markets 
AI
